Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.’ Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
Crossref DOI link: https://doi.org/10.1038/bjc.2015.331
Published Online: 2015-09-15
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cardillo, Giuseppe
Mokhles, Sahar
Williams, Norman
Macbeth, Fergus
Russell, Christopher
Treasure, Tom
Text and Data Mining valid from 2015-09-15
Article History
First Online: 15 September 2015
Competing interests
: The authors declare no conflict of interest.